Compounded Injectable Formula F1 Recalled for Lack of Sterility Assurance
Olympia Compounding Pharmacy is recalling Formula F1, a compounded injectable medication, due to lack of sterility assurance. The 1,703 vials were distributed nationwide.
What this means for you
Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.
Our severity reasoning: FDA Class II recall without reported hospitalizations. Lack of sterility assurance in an injectable pharmaceutical is a risk-of-harm product where injury has not yet been reported, meeting the criteria for High (3) per the rubric.
Plain-English summary
Olympia Compounding Pharmacy dba Olympia Pharmacy is recalling Formula F1 compounded injectable medication due to lack of assurance of sterility. The product contains Papaverine 1.8 mg/mL, Phentolamine 0.2 mg/mL, Alprostadil 18 mcg/mL, and Atropine 0.02 mg/mL.
The recall affects 1,703 vials distributed nationwide in the USA, Puerto Rico, and the US Virgin Islands. Affected product includes 2.5 mL multi-dose vials (NDC 73198-0001-03) and 10 mL multi-dose vials (NDC 73198-0001-10). Affected lots are K41C09 and K41B09 with a beyond-use date of November 9, 2022, and lot A24C19-22 with a beyond-use date of January 19, 2023.
The lack of sterility assurance in a multi-dose injectable vial creates a potential risk of microbial contamination and infection.
The recalled product
- Product
- Formula F1 Papaverine 1.8 mg/mL Phentolamine 0.2 mg/mL Alprostadil 18 mcg/mL Atropine 0.02 mg/mL, Packaged as a)2.5 mL Multi-Dose vial, NDC 73198-0001-03; b) 10 mL Multi-Dose vial, NDC 73198-0001-10; Rx Only, Olympia Pharmaceuticals, 6700 Conroy Rd., Ste. 155 Orlando, FL 32835
- Category
- Drug — Compounded Injectable
- Affected units
- 1,703
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (3)
- Lots: K41C09
- K41B09 BUD: 11/9/2022
- and A24C19-22 BUD: 1/19/2023
Distribution
Part of a larger recall action
This product is one of 53 recalled by Olympia Compounding Pharmacy dba Olympia Pharmacy under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 53 products in this recall →Related recalls
Same manufacturer · Olympia Compounding Pharmacy dba Olympia Pharmacy
See all →- HighFDA Recalls Compounded Papaverine Injection Due to Sterility Assurance
FDA (Drugs) · 2022-06-01
- HighFDA Recalls Amino Blend Injectable Vials Due to Sterility Concerns
FDA (Drugs) · 2022-06-01
- HighFDA Recalls Testosterone Cypionate Injection Vials for Lack of Sterility Assurance
FDA (Drugs) · 2022-06-01
- HighCompounded pharmaceutical vials recalled due to sterility assurance failure
FDA (Drugs) · 2022-06-01
- HighOndansetron Hydrochloride vials recalled due to sterility assurance concerns
FDA (Drugs) · 2022-06-01
Same hazard · sterility failure
See all →- SevereROHTO DIGI-EYE Eye Drops Recalled Over Sterility Assurance Gap
FDA (Drugs) · 2026-07-29
- HighROHTO DRY-AID Eye Drops Recalled Due to Sterility Concerns
FDA (Drugs) · 2026-07-29
- SevereTransvenous Pacing Electrode Tray with Bipolar Balloon Pacing Electrode Recalled
FDA (Devices) · 2026-07-22
- SevereArterial Line Kit with Lidocaine HCL Injection Fails Sterility Testing
FDA (Devices) · 2026-07-22
- SevereOne-Piece Introducer Tray kits recalled for sterility failure
FDA (Devices) · 2026-07-22